sur ORPHAN SYNERGY EUROPE-PHARMA (EPA:OSE)
OSE Immunotherapeutics to Hold Annual General Meeting on June 24, 2026
Nantes, France - OSE Immunotherapeutics SA announced the scheduling of its Annual General Meeting on June 24, 2026, at 10:00 am CET. The meeting is set to occur at Jones Day's offices in Paris, France, with an option for shareholders to join via a live webcast on the company's website.
An agenda and draft resolutions for the meeting were published on May 20, 2026, in French BALO. A notice containing further details will follow on June 8, 2026. Shareholders can access preparatory documents on OSE Immunotherapeutics’ website or request them via email, provided proof of shareholder status is furnished.
These steps are in alignment with French Commercial Code articles ensuring transparency and accessibility to information imperative for shareholder engagement.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de ORPHAN SYNERGY EUROPE-PHARMA